QUIVIVE Trademark

Trademark Overview

On Wednesday, December 12, 2018, a trademark application was filed for QUIVIVE with the United States Patent and Trademark Office. The USPTO has given the QUIVIVE trademark a serial number of 88227052. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 8, 2022. This trademark is owned by Quivive Pharma Inc.. The QUIVIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions comprising a therapeutic agent and a respiratory stimulant for the amelioration of pain
quivive

General Information

Serial Number88227052
Word MarkQUIVIVE
Filing DateWednesday, December 12, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 8, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements

Goods and ServicesPharmaceutical compositions comprising a therapeutic agent and a respiratory stimulant for the amelioration of pain
Pseudo MarkQUI VIVE
Translation of Words in MarkThe English translation of "QUIVIVE" in the mark is "alert".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuivive Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewbury Park, CA 91320
Party NameQuivive Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewbury Park, CA 91320

Trademark Events

Event DateEvent Description
Monday, August 8, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 8, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 11, 2022SOU EXTENSION 5 GRANTED
Monday, January 3, 2022SOU EXTENSION 5 FILED
Tuesday, January 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 3, 2022SOU TEAS EXTENSION RECEIVED
Saturday, July 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 1, 2021SOU EXTENSION 4 GRANTED
Thursday, July 1, 2021SOU EXTENSION 4 FILED
Thursday, July 1, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 20, 2020SOU EXTENSION 3 GRANTED
Sunday, December 20, 2020SOU EXTENSION 3 FILED
Sunday, December 20, 2020SOU TEAS EXTENSION RECEIVED
Friday, July 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 1, 2020SOU EXTENSION 2 GRANTED
Wednesday, July 1, 2020SOU EXTENSION 2 FILED
Wednesday, July 1, 2020SOU TEAS EXTENSION RECEIVED
Saturday, December 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2019SOU EXTENSION 1 GRANTED
Thursday, December 19, 2019SOU EXTENSION 1 FILED
Thursday, December 19, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 1, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, March 31, 2019ASSIGNED TO LIE
Monday, March 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 11, 2019EXAMINER'S AMENDMENT ENTERED
Monday, March 11, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2019EXAMINERS AMENDMENT E-MAILED
Monday, March 11, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, March 11, 2019ASSIGNED TO EXAMINER
Friday, January 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 15, 2018NEW APPLICATION ENTERED

Related Keywords

quivive stimulant amelioration pain respiratory agent compositions comprising therapeutic pharmaceutical